NCT03697447

Brief Summary

Mechanical massage or endermotherapyTM is applied to scar tissue with the intended therapeutic value being the promotion of structural or physiological changes. These proposed changes are meant to induce more pliability, so that skin possesses the strength and elasticity required for normal mobility. The advantage of mechanical massage compared to manual massage is that it provides a standard dosage using rollers and suction valves to mobilize the tissue. However, research documenting and supporting this effect is lacking. The objective of this proposal is to document the effect of 12 weeks of endermotherapy treatment on hypertrophic scar characteristics, including erythema, pigmentation, pliability, and thickness in adult burn survivors and their subjective evaluation of itch, pain and overall scar outcome through a prospective, randomized, controlled, within-patient, single-blinded study.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
19

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2017

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 13, 2017

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

March 22, 2018

Completed
7 months until next milestone

First Posted

Study publicly available on registry

October 5, 2018

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 5, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 5, 2020

Completed
Last Updated

August 21, 2024

Status Verified

August 1, 2024

Enrollment Period

3 years

First QC Date

March 22, 2018

Last Update Submit

August 20, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Skin Thickness Changes

    Ultrasound skin measures, mm

    baseline, 12, 24 and 36 weeks

Secondary Outcomes (4)

  • Cutometer Skin Elasticity Changes

    baseline, 12, 24 and 36 weeks

  • Mexameter Skin Erythema Changes

    baseline, 12, 24 and 36 weeks

  • Itch Visual Analog Subjective Changes

    baseline, 12, 24 and 36 weeks

  • Pain Visual Analog Subjective Changes: VAS

    baseline, 12, 24 and 36 weeks

Study Arms (2)

Endermotherapy treated scar

EXPERIMENTAL

Endermotherapy massage treatment

Procedure: Endermotherapy

Control scar

NO INTERVENTION

No intervention, standard of care

Interventions

Endermotherapy massage (mechanic massage) of burn scar

Endermotherapy treated scar

Eligibility Criteria

Age14 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • females and males, of any race, 14 years or older,
  • a thermal injury,
  • at least 3 months post-burn so that the scars will be durable enough to tolerate the proposed forces,
  • at least 2 scar sites \>2.034 mm thick and within 0.5 mm of each other, and
  • signed the informed patient consent form

You may not qualify if:

  • subjects who have keloids,
  • with a diagnosis of psychiatric illness clearly documented in their medical file,
  • mechanism of injury is an electrical, chemical, or cold injury,
  • a dermatological conditions in the region of the evaluation site, that may interfere with the study results,
  • a suspected or known allergy to ultrasound gel,
  • unable to understand French or English, or
  • subjects who refuse to give informed consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Montreal Burn Unit

Montreal, Quebec, H2X 1C9, Canada

Location

Study Officials

  • Bernadette Nedelec, PhD

    CRCHUM

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 22, 2018

First Posted

October 5, 2018

Study Start

February 13, 2017

Primary Completion

February 5, 2020

Study Completion

February 5, 2020

Last Updated

August 21, 2024

Record last verified: 2024-08

Data Sharing

IPD Sharing
Will not share

Locations